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The availability of genome-wide expression data for the blood-brain barrier is an invaluable
resource that has recently enabled the discovery of several genes and pathways involved
in the development and maintenance of the blood-brain barrier, particularly in rodent
models. The broad distribution of published data sets represents a viable starting
point for the molecular dissection of the blood-brain barrier and will further direct the
discovery of novel mechanisms of blood-brain barrier formation and function. Technical
advances in purifying brain endothelial cells, the key cell that forms the critical barrier,
have allowed for greater specificity in gene expression comparisons with other central
nervous system cell types, and more systematic characterizations of the molecular
composition of the blood-brain barrier. Nevertheless, our understanding of how the
blood-brain barrier changes during aging and disease is underrepresented. Blood-brain
barrier data sets from a wider range of experimental paradigms and species, including
invertebrates and primates, would be invaluable for investigating the function and evolution
of the blood-brain barrier. Newer technologies in gene expression profiling, such as
RNA-sequencing, now allow for finer resolution of transcriptomic changes, including
isoform specificity and RNA-editing. As our field continues to utilize more advanced
expression profiling in its ongoing efforts to elucidate the blood-brain barrier, including
in disease and drug delivery, we will continue to see rapid advances in our understanding
of the molecular mediators of barrier biology. We predict that the recently published data
sets, combined with forthcoming genomic and proteomic blood-brain barrier data sets,
will continue to fuel the molecular genetic revolution of blood-brain barrier biology.
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1. HISTORICAL PERSPECTIVE ON DATASETS
In 1967 using exogenous peroxidase, Reese and Karnovsky
demonstrated the subcellular localization of the blood-brain bar-
rier (BBB) to be the endothelium forming the walls of vessels
in the brain (Reese and Karnovsky, 1967). Two structural char-
acteristics distinguished these endothelial cells from those in
the heart and skeletal muscle: the presence of tight junctions,
and the paucity of micropinocytotic vesicles. Early studies used
microscopy and immunohistochemistry to visualize the pres-
ence and localization of a handful of known proteins within
brain endothelial cells (BECs) (Risau et al., 1986), while in situ
hybridization filled in the gaps for questions about expression
patterns when antibodies were not available for specific targets.
Nearly fifty years later, the underlying genes and developmental
cascades that result in the unique traits of BECs are just beginning
to be understood. Current critical advancements in our ability to
both purify and culture BECs now allow for the study of their
Abbreviations: ABC, ATP binding cassette; BBB, blood-brain barrier; BEC, brain
endothelial cell; FACS, fluorescence activated cell sorting; HBMEC, human brain
microvessel endothelial cell; hCMEC/D3, human cerebral microvascular endothe-
lial cell line; HUVEC, human umbilical vein endothelial cell; LCM, laser capture
microdissection; miRNA, microRNA.
molecular mechanisms at an unprecedented level of breadth and
depth.
Since the seminal discovery that brain endothelial cells limit
the diffusion of blood-borne molecules, the following decades
of work have made it clear that the BBB is not just a physical
wall but a complex regulated physiology that allows the BECs to
determine the movement of ions, molecules and cells between
the blood and the neural tissue. At the heart of this physiol-
ogy are molecular and structural specializations of BECs that
differentiate them from endothelial cells in non-neural tissue.
BECs are held together by tight junctions, which form a tight
paracellular barrier that polarizes the cells into distinct luminal
and abluminal membrane compartments. This tight paracellu-
lar junction coupled with the extremely low levels of transcytosis
creates a physical barrier to hydrophilic molecules and allows cel-
lular transport properties to determine movement of molecules
between the blood and the brain. To regulate this movement,
BECs express a series of different transporters that generally fall
into two categories: efflux transporters and nutrient transporters
(for an in depth review of BBB transporters see Saunders et al.,
2013). Briefly, efflux transporters, such as ABCB1 (also known
as p-glycoprotein, or Pgp), face the luminal surface and use
energy generated from the hydrolysis of ATP to pump a wide
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array of lipophilic substrates up their concentrations gradients
into the blood, thus limiting the passive diffusion of hydrophobic
molecules into the brain. Nutrient transporters, such as Glut-1
(glucose transporter SLC2A1), Lat-1 (amino acid transporter
light chain, SLC7A5) and Mct-1 (monocarboxylate transporter,
SLC16A1), facilitate the movement of specific substrates down
their concentration gradients, allowing specific molecules into or
out of the brain. Thus, the BBB is not solely a physical barrier
but it is a series of complex regulated physiological specializa-
tions of the BECs that control the microenvironment of the
brain. Furthermore, work has demonstrated that many of these
specializations of the BECs are not intrinsic, but regulated by
interactions with neural cells including CNS pericytes and astro-
cytes, and immune cells including microglia and macrophages
(Hudson et al., 2005; Armulik et al., 2011). Identifying the molec-
ular signature of BECs and how they differ from ECs in other
tissues, as well as key cell-cell signaling interactions in the neu-
rovascular unit, are questions at the forefront in understanding
the physiology of the BBB.
2. THE UTILITY OF DATASETS AS RESOURCES
High quality gene expression data has significantly impacted
the direction of investigation by allowing for a better molecular
understanding of BBB development, function, and dysfunction.
Well-powered gene expression studies can validate hypothesis
driven queries or open previously unexplored avenues of research
in unbiased directions. Models of acute BBB dysfunction, such
as stroke or ischemia, aid in elucidating mechanisms of impair-
ment for development of therapeutics or preventative treatments.
An understanding of BBB-specific transporter, receptor, and ion
channel expression levels could benefit drug development efforts
by aiding in the design of selective compounds for those that
could evade efflux pumps (Pottiez et al., 2009) or utilize receptors
to enhance therapeutic uptake in brain (Yu and Watts, 2013).
The variety of questions and issues that can be addressed
related to BBB development and disease have vastly improved,
thanks in part to genetic engineering approaches in rodents and
other species, improved cellular isolation techniques, and the
availability of bioinformatics software and experts that facili-
tate the mining of data sets for relevant genes worthy of further
investigation. The combination of “big data” sets and molecular-
genetic tools is beginning to elucidate biological mechanisms in
many arenas, and our understanding of BBB biology is benefiting
from this revolution.
2.1. KEY PARAMETERS FOR BBB GENOMIC STUDIES
The cellular complexity of the BBB presents a significant obsta-
cle in the gathering of meaningful gene expression data. Brain
endothelial cells are surrounded by the mural cells–pericytes and
smooth muscle cells–and are further encapsulated by a base-
ment membrane (see Figure 1C). The ensheathment of the ves-
sels by astrocytic endfeet, likely receiving signals from neurons
and microglia, serve to further regulate brain vascular function
(Abbott, 2005). Therefore, these various cell types are intimately
connected and unite in maintaining the integrity of the BBB.
Thus a global analysis of BBB gene expression may necessitate
the co-purification and co-analysis of these important non-BEC
cell types along with BECs (Shusta, 2005). Early efforts to har-
vest brain vasculature for genomic analysis captured a majority
of the cell types associated with BECs of the neurovascular unit.
These earlier protocols relied on mechanical brain dissociation
to isolate microvascular components, a technique known as vas-
cular enrichment (Triguero et al., 1990; Boado and Pardridge,
1991), which uses a series of filtrations through nylonmembranes
or with glass beads followed with gradient centrifugation steps
(Betz et al., 1979; Yousif et al., 2007). This contrasted with laser
capture microdissection (LCM) methods for single capillary frag-
ment isolation, which allows for highly localized sampling from
specific human and mouse brain sections and could be restricted
to diseased regions (Ball et al., 2002; Mojsilovic-Petrovic et al.,
2004). Again, both methods do not specifically yield pure popula-
tions of BECs specifically, however, they do allow for a sampling of
cells associated with the neurovascular unit and generally enrich
for BECs for inferences to be drawn about CNSmicrovasculature.
Thus, several important considerations must be taken into
account when designing genomic experiments to analyze the BBB.
Themost important parameter is to determine the desired cells or
tissues to be analyzed and the method of purification. Because the
key properties of the BBB are specializations of BECs, many stud-
ies have used methods to purify ECs from brain tissue, whereas
others have used crude approaches to purify vessels (endothelial
cells and pericytes) or entire fragments of the neurovascular unit
(see Figure 1). In addition, the vasculature of the brain contains
many different segments of the vascular tree including arteries,
arterioles, capillaries, post-capillary venules, venules, and veins
(Dorr et al., 2007), all of which contain barrier properties but each
segment may have different transport, metabolic, signaling and
cell adhesion properties. Gradient centrifugation has been used
to specifically isolate microvessels (capillaries and post-capillary
venules), whereas purification based on markers of ECs will con-
tain BECs from all segments of the vascular tree. Also taken into
consideration should be the species from which the samples are
isolated, whether human, rodent or other model organism, and
whether to examine acutely purified or cultured cells. The second
parameter is the method of analysis. For transcriptomic gen-
eration of EST libraries, subtractive hybridization, microarrays
and RNA sequencing are all common methods to examine RNA.
Different methods of RNA extraction, including whole RNA,
mRNA, small RNA, and tagged-ribosome isolation can highlight
specific RNAs of interest. In addition, proteomics, metabolomics,
lipidomics, epigenomics, and other “omics” analysis can give an
even broader overview of the molecular composition of the BBB.
The third parameter is the effective comparisons used for dif-
ferential gene expression analysis. Identifying all the transcripts
in a given cell can be challenging to decipher, however, generat-
ing a comparison of two cells that vary only for a given function
can greatly narrow down the search for important genes. In the
case of the BBB, several important comparisons have been made,
including comparing BECs with whole brain extracts to identify
EC specific genes, as well as comparing BECs with peripheral
ECs to identify BBB-specific specializations (see Table 1 for a
summary of recent BBB expression profiling studies). The fourth
important parameter to determine is the physiological setting in
which to analyze the BBB. Much work has been done to identify
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 355 | 2
Huntley et al. Gene expression at the blood-brain barrier
Neuron
Capillary
lumen
(blood)
Basal
lamina
Neurovascular unit
CulturedTrans-well
Purified BECs
Isolated microvessels
Pericyte
Endothelial
cell
Astrocyte
Primary or
immortalized
FACS/Antibody-based
purification
LCM
Filtration/
Centrifugation
Brain
A
B
C
D
E
F
FIGURE 1 | Techniques for isolating BECs. (A) Laser capture
microdissection or (B) mechanical filtration of brain microvessels can be used
to isolate segments of the neurovascular unit (C). FACS or other antibody
based purification (D) can be performed to isolate BECs acutely. Isolated
microvessels (B) and purified BECs (D) can be further cultured in a trans-well
system (E) or other relevant in vitro culture systems (F). Experiments based on
the neurovascular unit (C), purified primary BECs (D) and cultured BECs (E,F)
will each provide valuable, but different insights into the biology of the BBB.
the gene expression signature of the BBB in a healthy adult
animal, but studies have also examined the BBB during devel-
opment, in different neurological disease settings, in mice with
different mutations that affect BBB formation and function, or
with the addition of different pharmacological agents. Each of
these parameters will greatly influence the data set obtained and
therefore careful consideration must be taken to ensure the best
method of BEC purification and analysis.
2.2. METHODS OF ANALYSIS
Earlier transcriptomic approaches that yielded important initial
insights on brain microvascular specific expression data included
suppression subtractive hybridization and serial analysis of gene
expression (SAGE) (Li et al., 2001; Shusta et al., 2002; Enerson
and Drewes, 2006; Calabria and Shusta, 2008). For a detailed
review on these techniques and early results, see Shusta (2005),
Pottiez et al. (2009). A distinguishing aspect of the SAGE study of
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Table 1 | Recent genomewide microarray expression data sets for the BBB.
Method of BBB isolation Relevant study details Species *Dev study Other Disease
tissues
ANTIBODY-BASED/FACS PURIFICATION
Ben-Zvi et al., 2014 Tie2-GFP embryonic ECs from brain and lung Mouse +
Tam et al., 2012 ECs from liver, lung, brain in embryo, pup, adult Mouse + +
Daneman et al., 2010a Adult VCs from liver, lung, brain (+ postnatal), BECs and parenchyma Mouse +
Daneman et al., 2010b BECs from PDGFRb KO mice; BECs and pericytes from wild-type Mouse +
Daneman et al., 2009 Tie2-GFP adult ECs from brain, liver and lung Mouse +
Lyck et al., 2009 Primary PECAM+ BMECs, cultured b.End5 cells and BMECs Mouse
LCM
Dieterich et al., 2012 Blood vessels associated with gliobastoma tumors Human +
Cunnea et al., 2010 Brain microvessels in multiple sclerosis patients Human +
Giger et al., 2010 Pyramidal neurons and vascular endothelium Human
Harris et al., 2008 Neurons and microvessels in schizophrenia patients Human + +
FILTRATION/CENTRIFUGATION
Wang et al., 2012a BMVs from Alzheimer’s patients and controls Human +
Armulik et al., 2010 BMVs from wild type, Tie2Cre, R26P+/0, pdgfb−/− (pericyte deficient) Mouse +
He et al., 2011 BMVs from adult male rats Rat
CELL CULTURE
Reijerkerk et al., 2013 Naive hCMEC/D3 cells with TNFα, IFNγ; astrocyte-media cultured Human
Lopez-Ramirez et al., 2013 hCMEC/D3 cells with TNFα and IFNγ Human +
Urich et al., 2012 hCMEC/D3 cells and human primary BECs Human
Barbier et al., 2011 HBECs with platelets ± TNF, plasmodium infected RBCs Human +
Himburg et al., 2010 BEC cultures and non-brain EC cultures Human +
Li et al., 2008 HBMECs treated with amyloid-β Human +
*Developmental stages. BEC, brain endothelial cell; BMEC, brain microvascular endothelial cell; BMV, brain microvessel; HBEC, human brain endothelial cell;
HBMEC, human brain microvessel endothelial cells; EC, endothelial cell; RBC, red blood cell; VC, vascular cell.
rat brain microvessels was the comparison to rat neocortex and
hippocampus tag catalogs and the resulting identification of 864
BBB enriched genes.
Today, expression microarrays offer a mature and commonly
used platform to differentially compare gene expression between
two samples. One of the earliest BBB gene expression stud-
ies using microarray established a protocol to profile human
brain endothelial cells co-cultured with astrocytes under dynamic
conditions with controlled intraluminal flow (Marroni et al.,
2003). The authors observed that exposure to increased flow
up-regulated cytoskeletal genes while also inhibiting cell cycling
genes.
In the era of microarray data sets on the BBB (see Table 1),
the number of genes that are queried on commercially available
chips has increased several orders of magnitude, moving the field
into truly high-throughput experiments and data. In addition,
relatively small amounts of cells or tissue are now required for
genome-wide transcriptomic approaches, thus facilitating a wide
range of studies. Advancements and maturity of computational
tools for this type of data analysis are now available allowing
investigators to dive into these data sets and identify meaningful
connections (Irizarry et al., 2003; Gentleman et al., 2004; Smyth,
2004; Falcon and Gentleman, 2007; Kauffmann et al., 2009).
Online repositories, such as Gene Expression Omnibus and the
European Nucleotide Archive, now allow researchers to deposit
genome wide expression data sets to be queried and re-used by
other groups. Indeed, many of the studies listed in Table 1 have
made use of previously published expression data sets from the
BBB as an integral part of their analyses. The importance of con-
tinuing to expand the public availability of such data sets as an
ongoing resource for the community cannot be overstated.
A discussion of newer techniques, such as next generation
RNA-sequencing, will follow at the conclusion of this review.
3. EXPERIMENTAL PARADIGMS ANALYZED
Figure 1 summarizes the most common methods for isolation
and purification used in BBB genome-wide expression studies. As
many recent studies have shown, in vitro models of the BBB do
not fully recapitulate the complexity of an intact organism. The
use of newer techniques such as fluorescence activated cell sorting
(FACS), immunopanning, magnetic bead immunoprecipitation,
as well as advances to LCM may aid in acutely harvesting specif-
ically BECs, or an enriched population of BECs, for downstream
transcriptomic and proteomic studies. Navone et al. (2013) doc-
ument recent protocols for the isolation of human and mouse
brain microvascular endothelial cells. However, no technique or
protocol is perfect as there are subtle considerations to be aware
of which may factor largely into downstream data analysis. Even
careful acute isolation and genomic profiling of BECs may be
susceptible to general expression changes induced by mechanical
shearing of brain parenchyma and/or microvessel tissue, enzy-
matic digestion, temperature fluctuations, etc. Careful pair-wise
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 355 | 4
Huntley et al. Gene expression at the blood-brain barrier
comparisons with the proper controls undergoing similar han-
dling are critical to minimize bias in the data.
3.1. ACUTE ISOLATION AND PURIFICATION OF BRAIN
MICROVASCULAR CELLS
The use of antibody-based techniques to isolate rodent brain
endothelial cells has been reported in several recent studies.
Magnetic beads coupled to murine or rat antibodies against
CD31/PECAM allow for immunoprecipitation of endothelial
cells from homogenates of brain (Lyck et al., 2009) and possibly
other vascular organs for direct comparisons. Likewise, antibod-
ies against CD31 can be immobilized onto culture plates for
immunopanning enrichment of brain homogenates for acute iso-
lation of BECs (Zhou et al., 2014a) or the use of other cell surface
receptors such as anti-PDGFRβ for pericytes (Daneman et al.,
2010b). This approach also allows for a negative selection step
against microglia or pericytes to remove these non-BEC sub-
types from the overall homogenate. A third BEC-specific antibody
or antigen-selection technique utilizes fluorescence-activated cell
sorting which would use either a fluorophore-coupled anti-BEC
cellular marker (Daneman et al., 2010b; Tam et al., 2012) or trans-
genic mice that harbor BEC-specific promoters to direct expres-
sion of a fluorescent protein, such as Tie2-GFP mice (Daneman
et al., 2009, 2010a; Ben-Zvi et al., 2014).
Moreover, LCM has experienced many improvements includ-
ing the addition of immunostaining protocols and brighter, more
specific dyes for identification of brain endothelia (Macdonald
et al., 2008). Recent immuno-LCM studies have described dif-
ferences in gene expression of brain capillaries vs. venules, and
highlighted important roles for their heterogeneity (Macdonald
et al., 2010). Increased antibody availability for other neurovas-
cular unit cell types have also enabled cross comparison of gene
expression as well as validation of cell type specificity of the
data sets generated by mass spectrometry (Murugesan et al.,
2011). Advances in equipment such as microscopes with auto-
mated stages, higher quality cameras, and sophisticated soft-
ware have enabled more consistent tissue sampling and higher
throughput.
3.2. IN VITRO BBB MODELS
Immortalized cell lines derived from rodent or human brain
endothelial cells have been frequently used as a model system
for gene expression studies despite their questionable physio-
logical relevance. Cultured cells, especially those that can be
passaged indefinitely, represent a key model system that allows
for a high level of cellular homogeneity, consistency, and exper-
imental reproducibility. Key components of the neurovascular
unit can be reconstituted in vitro by growing BECs on filter
inserts that sit above pericytes and/or astrocytes, allowing sig-
naling mechanisms between these cell types to remain largely
intact. Conversely, in vitro models may still lack the complex
interactions between these cell types and the endogenous extra-
cellular matrix, as well as surrounding neurons andmicroglia that
exist in vivo. Complicated disease processes that are also in play
in vivo are likely difficult to fully model in a transwell culture sys-
tem and suffer from numerous drawbacks (Hawkins and Egleton,
2008; Pottiez et al., 2009). In other words, the neurovascular
unit is essentially an organ system with numerous cellular inter-
actions that make it virtually impossible to replicate outside of
the organism. However, these culture paradigms also do enable
investigators to determine what individual cell types can do in
the absence of other cells, or with defined cellular interactions.
For instance, culturing BECs alone can give an idea of which
BBB properties are independent of signaling interactions within
the neurovascular niche. Furthermore, by adding feeder layers
of individual cells, such as astrocytes or pericytes, or signaling
molecules or pharmacological agents, in vitro models can aid
in determining how these factors directly influence BEC gene
expression.
Primary BEC culture models obtained from bovine or rodent
acutely isolated brain microvessels present another system for
directed studies on BBB maintenance and function. Early efforts
relied on isolation and enrichment of brain capillaries from rats
followed by enzymatic digestion of the basement membrane to
allow migration of endothelial cells for growth on an artificial
substrate (Bowman et al., 1981). Bovine models have allowed
for several benefits including greater amounts of starting mate-
rial obtained from one animal, less variability between cultures
from the same starting material, and importantly, retention of
endothelial characteristics after serial passaging (Goetz et al.,
1985).
The establishment of human cerebral microvessel cultures also
yielded early, important insights into BBB function (Vinters et al.,
1987). These culture systems were improved upon as tighter bar-
riers were introduced with co-culture models containing astro-
cytes and by introducing intraluminal flow (Marroni et al., 2003).
Human brain microvessel endothelial cells (HBMEC) have also
been treated with amyloid-β to determine their gene expression
changes using a cDNA array and identified a putative protective
role for STC1 (Li et al., 2008).
3.3. COMPARISONS OF ACUTE VS. CULTURED BBB MODELS
Whether in vitro BBBmodels were derived from immortalized cell
lines or acutely isolated from mouse or human brains, extensive
efforts to characterize their gene expression signature have repeat-
edly revealed their limited approximation of in vivo complexity.
Comparisons of BBB gene expression profiles from acutely iso-
lated mouse brain endothelial cells vs. a period of brief culturing,
or compared against a commonly used mouse brain endothe-
lioma line (bEND5) revealed evidence of dedifferentiation of BEC
qualities (i.e., reduced levels of tight junction proteins and amino
acid transporters) induced by primary culture or immortalization
(Lyck et al., 2009). A similar study which used suppression sub-
tractive hybridization revealed that some transport-related brain
endothelial genes were subsequently downregulated after BECs
spent several days in culture compared to freshly isolated rat brain
microvessels (Calabria and Shusta, 2008). The same study com-
pared cultures containing puromycin (which decreases numbers
of contaminating pericytes) for BEC expression and also the effect
of hydrocortisone on cultures. More recently, transcriptome data
from immortalized human BEC line hCMEC/D3 and primary
human BEC (Urich et al., 2012) were compared with published
data on acutely isolated mouse BECs (Daneman et al., 2010a) to
highlight differences in levels of endothelial marker expression.
www.frontiersin.org November 2014 | Volume 8 | Article 355 | 5
Huntley et al. Gene expression at the blood-brain barrier
The authors found that although the human cells demonstrated
expression of tight junction proteins, transporters and recep-
tors, their levels were dramatically reduced compared to acutely
isolated mouse BECs (Urich et al., 2012).
Nevertheless, using in vitro BBB models may yield some
important initial insights into BEC response to external stimuli
or stress. hCMEC/D3 cells have been recently profiled for their
transcriptional response to TNFα and IFNγ and gene expres-
sion signatures identified span from factors involved in antigen
presentation, cellular adhesion, cytokine-induced signaling path-
ways, to reduced transporter expression (Lopez-Ramirez et al.,
2013). These data were compared to similar historical data sets
that included TNFα-treated human umbilical vein (HUVEC) and
primary human cerebral endothelial cell cells (Franzen et al.,
2003).
3.4. MODELS OF BBB DEVELOPMENT
Wnt/β-catenin signaling has been implicated in driving CNS
specific angiogenesis and regulating BBB formation and mainte-
nance (Liebner et al., 2008; Stenman et al., 2008; Daneman et al.,
2009; Wang et al., 2012b; Zhou et al., 2014b). Using microarray
expression profiling comparing BECs with ECs from non-neural
tissue, Daneman and colleagues identified that genes downstream
of Wnt/β-catenin signaling were greatly enriched in endothe-
lial cells of the brain but not liver or lung (Daneman et al.,
2009, 2010a). Performing sophisticated genetic and functional
experiments, the authors demonstrate that Wnt/β-catenin sig-
naling is required to drive CNS-specific angiogenesis but not
angiogenesis in other tissues. To identify if this CNS-specific
angiogeneic program also induced BBB-specific gene expression
in the endothelial cells, the authors utilized gene expression pro-
filing of purified mouse brain endothelial cells cultured with and
without Wnt ligands to find that Wnt induced the expression of
BBB-specific nutrient transporters in the endothelial cells, and
further showed that loss of Wnt signaling in vivo led to loss of
Glut-1 expression in endothelial cells. More recently, Zhou et al.
(2014b) demonstrated nearly identical canonical Wnt signaling
mechanisms of development and maintenance between both the
blood-brain and blood-retinal barriers.
The characterization of molecular cues and signaling pathways
that guide both physiological and pathophysiological CNS angio-
genesis may also stand to benefit greatly from expanded efforts
at expression profiling of BECs within various parts of the neu-
rovascular unit. Common guidance molecules that regulate both
nerve and vascular remodeling such as Sema/Plex/Nrp, Slit/Robo,
Netrin/Unc5, VEGF, and its tyrosine kinase receptors Flt-1 and
Flk-1, have been extensively studied, however, the role of the
canonical axon guidance molecules in CNS angiogenesis is less
studied (Tam and Watts, 2010). Transcriptomics may also enable
future studies on understanding the role of TGFb or EphB recep-
tors and ligands in determining arteriovenous identity within
the brain vasculature (Adams and Alitalo, 2007; Engelhardt and
Liebner, 2014).
In addition to the involvement of Wnt signaling in BBB
angiogenesis and barriergenesis, the role of growth factors and
kinases beyond VEGF and Notch have also been further charac-
terized. Mice deficient in PDGF-B lack microvascular pericytes
and succumb to lethal microaneurisms during development due
to incomplete brain vascularization (Lindahl et al., 1997). More
recent studies on the importance of pericytes in barriergene-
sis and maintenance reported that significantly reduced pericyte
coverage in PDGFRβ null fetal mice translated into increased per-
meability (Daneman et al., 2010b). Transcriptome signatures of
BECs isolated from null mice were compared to wild type mice,
which revealed increases in Angpt2, a Tie2 ligand involved in
vascular permeability of peripheral endothelial cells but no down-
regulation of BBB-enriched genes. Thus pericytes may regulate
the BBB by inhibiting the expression of genes that normally make
endothelial cells leaky. In addition, the expression profile of per-
icytes acutely isolated from wild type mice was also generated,
further providing a valuable data set for BBB neurovascular unit
transcript comparisons (Daneman et al., 2010b).
For an in depth review on recent studies of developmental bar-
riergenesis and repair, see Obermeier et al. (2013), Siegenthaler
et al. (2013), Engelhardt and Liebner (2014).
3.5. EVOLUTIONARY STUDIES OF THE BBB
Two distinct cellular mechanisms of BECs appear to be evolu-
tionarily conserved across all vertebrates and some invertebrates,
including the fruit fly model organism, Drosophila melanogaster.
These conserved traits include the tight junctions that prevent
paracellular diffusion, and ATP binding cassette (ABC) trans-
porters that effluxmolecules back into the vascular luminal space.
The Drosophila genome encodes proteins which are nearly iden-
tical in sequence to those that comprise vertebrate tight junctions
(Wu and Beitel, 2004; Banerjee et al., 2006), and whose disruption
leads to defects in humoral-CNS barrier function (Schwabe et al.,
2005; Stork et al., 2008). Further, Mayer et al. (2009) established
that the fly protein Mdr65 functions as an ABC transporter in the
Drosophila hemolymph-brain barrier.
Validation of gene expression data in other species with a
simplistic BBB may expedite the search for candidate genes that
warrant further study in rodents or human tissue. For example,
we recently profiled the rodent BBB at three developmental stages,
used zebrafish to confirm the necessity of candidate genes in reg-
ulating angiogenesis, and followed with subsequent analysis of
genetic interactions of two death receptors, DR6 and TROY, by
returning to mice to confirm a role for these genes in rodent BBB
development (Tam et al., 2012). As such, conserved pathways can
be discovered in one species and further characterized in more
tractable models. In fact, fruit fly, grasshopper, and zebrafish are
gaining popularity as models for high throughput screening of
BBB drug permeability studies (Nielsen et al., 2011; Geldenhuys
et al., 2012) It is this underlying premise of evolutionary con-
servation which provides confidence that understanding the BBB
in rodent and other model organisms will be relevant to the
human BBB.
Primate studies, on the other hand, can illuminate more
recent evolutionary innovations relevant to the human BBB. Gene
expression differences between neurons and BECs from human
postmortem tissue isolated by LCM were compared with pub-
lished data sets on chimpanzees and rhesus macaques for analysis
of rates of transcriptome evolution in neuronal vs. endothelial cell
types (Giger et al., 2010). The authors found that transcriptomes
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of neurons and endothelial cells evolve at different rates within
brain tissue. This finding adds complexity to the challenge of
translating BBB results from other species, even closely related
species, into human models.
3.6. HUMAN BBB DATA SETS FOCUSED ON AGING, DISEASE, AND
DYSFUNCTION
During normal aging, the blood brain barrier experiences func-
tional changes, which can result in impairment and dysfunc-
tion of the barrier. Marques et al. (2013) provide a review
of these changes in both the BBB and blood-CSF barriers. In
the BBB, these changes include loosening of tight junctions,
increases in pinocytotic vesicles, and decreases in mitochon-
drial density within ECs. The authors highlight the similarity
between normal aging, and CNS disease related changes of the
BBB. Since human BBB data from patients typically comes from
those with obviously progressed symptoms, it is a challenge to
determine if the changes in BBB function are causal or conse-
quential to disease progression. Improvements in animal models
of CNS diseases with BBB impairment may help answer such
questions.
Nevertheless, several human studies in diverse disease
paradigms have sought to understand vascular expression differ-
ences between healthy control and disease tissue. Microvascular
endothelial cells from postmortem schizophrenia brains were
isolated by LCM and their functional profile was compared to
neurons and control tissue in a study by Harris et al. (2008).
They found that the cerebral microvasculature of schizophrenic
patients displayed a hypo-inflammatory status and this observa-
tion was reproducible on a separate microarray platform. This
gene set could be useful in comparison studies with similar rodent
models of cognitive dysfunction or with human BBB gene sets
from patients with other cognitive or behavioral impairments.
Likewise, the use of LCM to isolate vessels from glioblastomamul-
tiforme brain tissue followed by microarray analysis and qPCR
validation identified uniquely upregulated genes specific to tumor
tissue and absent in nonmalignant human brain (Pen et al., 2007).
Interestingly, a similar study from another group did not identify
the same upregulated genes and describe a different expression
signature (Dieterich et al., 2012). Another recent study also used
LCM to query genes expressed at the BBB from multiple scle-
rosis lesions isolated from postmortem tissue (Cunnea et al.,
2010).
Brain endothelial cell transcriptomes from human neu-
rodegenerative diseases have been distinctly underrepresented.
However, there is no shortage of studies reporting genome-wide
data sets from Alzheimers disease brain or sub-regions such as
hippocampus (Blalock et al., 2004; Dunckley et al., 2006; Webster
et al., 2009; Blalock et al., 2011). To the best of our knowledge,
the only published data set generated thus far representing the
BBB in human neurodegeneration is from a study where brain
microvessels from control and Alzheimers disease tissue were
transcriptionally profiled to identify abnormal gene expression or
differentially expressed genes (Wang et al., 2012a). A comparison
of this data set with brain microvasculature gene expression data
derived from mouse models of Alzheimer’s disease may serve as a
useful tool for model validation.
3.7. RODENT BBB DATA SETS IN MODELS OF NEURODEGENERATION
AND DISEASE
Transgenic mouse models of Alzheimers disease have been instru-
mental to the study of amyloid-β accumulation and its role in
neuronal impairment and cognitive dysfunction. Transcriptome
analysis of whole brain, specific subregions, various disease time
points, and in multiple Alzheimer’s disease transgenic models
or after experimental treatments has been performed (Dickey
et al., 2003; Reddy et al., 2004; Lazarov et al., 2005; Gatta
et al., 2014). Genomic studies specifically using mouse brain vas-
culature from Alzheimer’s disease models, on the other hand,
remain sparse. Themost recent study used a proteomics approach
from homozygous Tg-SwDI mice which harbor three familial,
autosomal dominant mutations on APP, and demonstrate sus-
tained increases in vascular amyloid-β accumulation over time
(Searcy et al., 2014). The authors compared brain microves-
sel fractions from 3- and 9-month old wild type and trans-
genic mice for aging-related effects on the mouse vascular pro-
teome as well as amyloid-β-induced effects. They found dis-
tinct sets of proteins changed in young and old wild type and
transgenic mice, indicating a differential effect of age on the
cerebrovasculature.
An experimental mouse model of multiple sclerosis, experi-
mental autoimmune encephalomyelitis, is characterized primar-
ily by dysfunction of the BBB. Functional studies have pro-
duced insights into the role of particular genes, such as the
chemokine CXCL12, and the permeability of the BBB in exper-
imental autoimmune encephalomyelitis (McCandless et al., 2006,
2009). However, to our knowledge, there does not yet exist a
genome wide expression data set derived from the BBB in this
important model of multiple sclerosis.
Metabolic diseases, with obesity a leading factor, may also have
a multitude of effects on the BBB and as a result, CNS function.
A recent study on diet-induced obesity using a mouse model pro-
filed the proteomic changes in brain vasculature after 2 months
of high fat diet chow administered starting at 2 months of age
(Ouyang et al., 2014). The samples were compared directly with
mice maintained on normal chow and the authors found 47
downregulated and 2 upregulated proteins, indicating that in gen-
eral, diet-induced obesity suppressed metabolic activity in brain
microvessels (Ouyang et al., 2014).
Rodent models exist for other neurological diseases associated
with BBB dysfunction, including stroke, epilepsy, ALS, and neu-
romyelitis optica. However, to date, there is a void of genome
wide expression data on brain endothelial cells from these impor-
tant models. Future data sets derived from these models will be
invaluable in bridging the knowledge gap between our under-
standing of healthy BBB maintenance and BBB dysfunction in
disease.
Another genomic data set that is publicly available and could
be used as a valuable cross-reference tool describes the tran-
scriptional changes in four rat brain tissues/regions including
striatum, and parietal cortex, choroid plexus, and the meninges
and its associated vasculature (Bowyer et al., 2013). This study
also included a time course analysis to profile the effects of
amphetamines or environment-induced hypothermia on choroid
plexus and the meninges.
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4. SUMMARY OF INSIGHTS FROM BBB GENOMIC STUDIES
4.1. OVERVIEW
Genomic studies on the BBB have provided a number of large
data sets identifying genes that are expressed by BECs, enriched
in BECs compared to peripheral ECs, and also genes that change
levels during development or disease context. The challenge now
is to sort through these vast data sets and untangle which of these
large numbers of genes are functionally important for the forma-
tion and function of the BBB, and which can be targeted to either
modulate the BBB during neurological disease or to use as carri-
ers for drug delivery across the BBB. Two positive outcomes have
arisen from these data sets: (1) many of these analyses that use
completely different methodologies have identified the same BBB
genes, and (2) virtually all of the data sets have verified the expres-
sion and BBB-enrichment of commonly studied genes important
for BBB function including tight junctions (claudin 5, occludin,
Zo-1, Zo-2), efflux transport (P-glycoprotein, and ABCG2, also
known as Bcrp), nutrient transport (Glut-1, Mct-1, Lat-1) and
others (basigin, carbonic anhydrase 4). The strong reproducibility
and ability to verify positive hits suggests that these data sets will
indeed provide an extremely strong blueprint for identification of
novel genes important for BBB function.
4.2. SIGNALING REGULATORS
Several important discoveries have already been generated from
these data sets. For instance, the identification that a cluster of
Wnt/β-catenin signaling components and downstream targets
(Fzd6, Lef1, Axin2, Dixdc1, Apcdd1, Troy) are greatly enriched in
BECs compared to peripheral ECs led to the hypothesis that Wnt
may be an important regulator of the BBB. As discussed above,
several groups have verified and identified that Wnt/β-catenin
signaling is required for driving CNS-specific angiogenesis, BBB
induction and maintenance (Liebner et al., 2008; Stenman et al.,
2008; Daneman et al., 2009; Wang et al., 2012b). Beyond the
morphogens Wnt and Shh, and the canonical VEGF and Notch
signaling pathways, a further understanding of other growth fac-
tors and kinases involved in angiogenesis have also been possible
from expression data. Moreover, gene cluster/pathway analysis
can provide an important method to sift through large data sets
to find groups of genes that are functionally important. Other
clusters associated with BBB-enrichment are genes involved in
retinoid signaling, amino acid metabolism and glycolysis, sug-
gesting that these may be important for unique function of
BECs.
4.3. MOLECULAR COMPONENTS OF THE BARRIER
Many groups have used these data sets to identify individual
genes that are important for BBB function. Lipolysis stimulated
receptor (Lsr) was identified as enriched in BECs compared to
peripheral ECs (Daneman et al., 2010a), has recently been shown
to recruit tricellulin/Marveld2 to tricellular tight junctions for the
formation of epithelial barriers (Masuda et al., 2011), and could
potentially have a similar function at the BBB. Like Lsr, Marveld2
was identified as enriched at the BBB along with other tight junc-
tion components such as Jam4,Mpp7 and Cgnl1 (Daneman et al.,
2010a), suggesting that these may also be important for forma-
tion of BBB tight junctions. Interestingly, the genomic data sets
have not added much clarity as to which claudins may be impor-
tant for BBB function. While it is well established that claudin 5
is most critical in transmembrane adhesion for BEC tight junc-
tions (Nitta et al., 2003), various studies have also implicated
claudin 1, claudin 3, claudin 12 and other claudins as expressed
by BECs (Liebner et al., 2000; Nitta et al., 2003; Wolburg et al.,
2003; Krause et al., 2008; Pfeiffer et al., 2011). Several different
genomic data sets have essentially come to different conclusions
as to which claudins are expressed by BECs. Array studies on
purified mouse BECs have suggested that in addition to claudin
5, claudin 12 is the other claudin expressed by BECs (Daneman
et al., 2010a; Tam et al., 2012), while cultured cells have identi-
fied claudin 3 as a component of BEC tight junctions (Liebner
et al., 2008), and proteomics on human passaged endothelial cells
have identified a wider array of claudins present at these junctions
(Ohtsuki et al., 2013). These differences may result from species
differences, differences in acutely isolated vs. cultured cells, or dif-
ferent sensitivities of analyses, and further work needs to be done
to determine which are the important molecules.
4.4. TRANSPORTERS AND DRUG DELIVERY TARGETS
The genomic data sets have also identified a huge number
of molecular transporters highly expressed and enriched in
BECs compared to peripheral ECs. In addition to widely stud-
ied BBB transporters (Glut-1, Lat-1, Mct-1), a number of
other transporters have been identified and include molecules
that transport neurotransmitters (Slc6a6, Slc6a17), thiamine
(Slc19a3), nucleotides (Slc25a33), carnitine (Slc25a20), zinc
(Slc20a1, Slc39a10) and riboflavin (Slc52a2/Gpr172b) (Lyck et al.,
2009; Daneman et al., 2010a). Determining the expression and
function of this wide array of transporters may be important
to understand the nutrient requirements of the CNS. A recent
study by Ben-Zvi et al. (2014) selectively profiled E15.5 embryos
for transcripts enriched at the BBB vs. lung endothelium and
identified Mfsd2a, a lipid transporter required for docosahex-
aenoic acid transport (Nguyen et al., 2014), further confirming its
high expression levels. Analyzing the expression of transporters
and signaling components may also identify novel molecules to
target for drug delivery to the CNS. The most commonly uti-
lized target for BBB-specific receptor-mediated drug delivery to
the CNS is transferrin receptor, which has been identified as
highly expressed and enriched in BECs by a number of data
sets (Li et al., 2001; Enerson and Drewes, 2006), suggesting
that other targets may also be identified. Interestingly, a pep-
tide targeting Lrp1 has been shown to target molecules across
the BBB, however, several genomic studies identified Lrp8, and
not Lrp1, as highly expressed and enriched in BECs (Daneman
et al., 2010a; Tam et al., 2012). For a detailed review on the
expression of transporters at the blood-brain and blood-CSF
interfaces in the developing and adult brain, see Saunders et al.
(2013).
5. EMERGING FRONTIERS
5.1. PROTEOMICS
One major criticism of transcriptomic approaches is that tran-
script abundance does not necessarily correlate with protein levels
and actual functional activity. To that end, proteomic approaches
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may nicely complement gene expression studies. For a detailed
review of proteomic studies which describe how various cell cul-
turing conditions can significantly affect protein profiles and
also how protein expression is explored using in vivo mod-
els of ischemia, stroke, inflammation, and disease, see Pottiez
et al. (2009). Additionally, global genomic approaches are often
followed with validation by qPCR assays and new develop-
ments in microfluidic devices have enabled higher throughput
of expression validation studies from the same profiled samples,
as well as the inclusion of a multitude of other samples, with
or without experimental treatments, or from disease models and
patients.
However, a major consideration of current proteomics BBB
data is again the purity of the cell population being queried. Many
BBB proteomics data are largely obtained from brain microvessel
preparations consisting of additional pericytic or astrocytic con-
nections that are in direct contact with BECs which are known
to contain concentrated levels of cell-type specific receptors or
channel proteins (see Table 2). Detection of known proteins such
as those expressed on astrocytic endfeet (Chun et al., 2011),
can be easily separated, however, lesser known hits may not
be readily segregated by cell type or fall within a general cat-
egory. A recent effort to profile one specific branch of CNS
vasculature, the arteries comprising the Circle of Willis, gener-
ated an extensive data set of 6630 proteins, of which a third
are specific to the cerebral arterial landscape (Badhwar et al.,
2014). Interestingly, because isolation of the sampled tissue was
via manual dissection and performed under light microscopy,
whole units of arterial mediators such as neuronal regulators of
vasoactivity, presumably from nerve terminals, as well as regula-
tors of smoothmuscle relaxation and contractility were identified.
The cerebral artery-specific proteomewas compared to themouse
microvessel proteome which revealed that intracortical microves-
sels had more BBB-unique protein numbers and that Circle of
Willis arteries were less developed and specialized compared to
microvessels (Badhwar et al., 2014). Additional studies have also
compared human brain microvessel proteomic signatures with
mouse (Uchida et al., 2011).
Investigators have tried to circumvent these issues by cou-
pling gene expression with proteomics in analyses of human brain
vasculature isolated from resected glioma or epileptic lesions
(Dauchy et al., 2008; Shawahna et al., 2011). Furthermore, a
proteomics report of young and aged primate brain microvas-
culature provides a highly quantitative snapshot of membrane
proteins expressed at the BBB at two stages of development (Ito
et al., 2011). The data were compared to mouse BBB proteomic
findings, which revealed significant differences. These compar-
isons may provide a cautionary note when translating findings
between rodents and primates, likely impacting nervous system
drug development studies focused on using mouse BBB models
to understand transporter and receptor expression levels (Kamiie
et al., 2008; Ito et al., 2011).
Overall, proteomic studies have been incredibly useful in iden-
tifying novel molecules. In particular, proteomic analysis of lipid
rafts isolated from cultured cells has identified leukocyte adhe-
sion molecules, ninjurin, Alcam, and Mcam, that are critical for
trafficking of specific subsets of immune cells into the CNS dur-
ing neuroinflammatory disease (Wosik et al., 2007; Cayrol et al.,
Table 2 | Recent proteomics data sets for the BBB.
Method of BBB isolation Relevant study details Species *Dev Other Disease
study tissues
LCM
Lu et al., 2008 Microvessels from CD31+ immunostained brain Mouse
Haqqani et al., 2005 In vivo ischemia Rat +
FILTRATION/CENTRIFUGATION
Badhwar et al., 2014 Surgical dissection of circle of Willis brain artery Mouse
Ouyang et al., 2014 Mouse model of diet-induced obesity and control Mouse +
Searcy et al., 2014 Effect of aging on BMVs from wild type and Tg-SwDI mice Mouse + +
Agarwal et al., 2012 BMVs from wild type and P-gp/Bcrp knockout Mouse
Chun et al., 2011 Membrane fraction of BMVs Mouse
Ito et al., 2011 BMVs from neonate, child, and adult Cyno monkey +
Shawahna et al., 2011 BMVs from epilepsy patients and glioma patients Human +
Uchida et al., 2011 Human and mouse BMVs Human and mouse
Kamiie et al., 2008 Membrane fraction of microvessels from brain, liver and kidney Mouse +
CELL CULTURE
Ohtsuki et al., 2013 hCMEC/D3 compared to isolated human BMVs and HUVECs Human +
Pottiez et al., 2010 BCECs co-cultured with glial cells Cow
Pottiez et al., 2009 BMECs cultured with and without astrocytes Cow
Lu et al., 2007 MECs from brain and heart Rat +
Haqqani et al., 2007 Immortalized BECs and in vitro ischemia Rat +
*Developmental stages. BCEC, brain capillary endothelial cell; BEC, brain endothelial cell; BMEC, brain microvessel endothelial cell; BMV, brain microvessel;
hCMEC/D3, human cerebral microvascular endothelial cell line; HUVEC, human umbilical vein endothelial cell.
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2008; Ifergan et al., 2011). This suggests that the cultured cells
may provide a model for “activated” endothelial cells and thus
a good model to study their interaction with immune cells that
might occur during neurological disease. In addition to these
established functions of the BBB, these data sets may identify
novel and unknown genes that could point to novel functions of
the BBB. Although a daunting task, examining the function and
regulation of each of these genes and pathways should provide
incredible insight into how our brain interacts with the humoral
space.
5.2. MicroRNA
MicroRNA (miRNA) arrays have also been used to identify and
understand their role in regulating gene expression levels at
the BBB in disease. Using hCMEC/D3 cells treated with TNFα
and IFNγ , Reijerkerk et al. (2013) set out to profile the micro-
RNAs that modulate BBB function under inflammatory
conditions. With a panel of miRNAs identified to have differ-
ential expression induced by inflammatory mediators that also
displayed opposing changes after barrier induction in the cell
line, the authors further examined their expression in brain
capillaries isolated via filtration from resected multiple sclerosis
patient lesions. These samples showed decreased expression of
miR-125a-5p (Reijerkerk et al., 2013). In another study using
a miRNA array of 318 candidates, mouse brain endothelioma
line bEND3 cells were profiled for altered miRNA expression in
response to lupus serum or C5a (Eadon et al., 2014). Studies
similar to these, for example evaluating freshly isolated BECs for
miRNA expression at different developmental times or in diverse
disease models, will further expand our knowledge of how gene
expression is regulated at the BBB.
5.3. RNA-SEQUENCING
RNA sequencing is a high-throughput, quantitative transcrip-
tomic approach that is rapidly gaining popularity (Lister et al.,
2008; Mortazavi et al., 2008; Nagalakshmi et al., 2008; Wilhelm
et al., 2008), especially as more genome annotations are com-
pleted for more and more species. RNA-seq data also allows for
the relatively unbiased discovery of alternative splicing within
transcripts. Where the bulk of our transcriptome based knowl-
edge has been driven by methods that illuminate overall gene
expression (including microarray and SAGE), we have until
recently, been lacking much of the important resolution afforded
by identification of alternative splicing events. Many of the genes
encoding proteins that form tight junctions and ABC trans-
porters, for example, have distinct isoforms resulting from alter-
native splicing events. Future additional RNA-seq experiments
with BBB data will provide a foundation for our future under-
standing of the relevance of such splicing behavior with respect to
barrier development, maintenance, and dysfunction.
The high-throughput sequencing of transcriptomes afforded
by RNA-seq technologies also facilitates the study of RNA editing.
The process of RNA editing, which is most prevalent in the brain,
is a post-transcriptional modification that can influence splicing
patterns, coding sequence, and a host of other gene regulatory
functions. Indeed, some of the best-studied RNA-editing events
that result in altered protein isoforms occur within neuronal
glutamate receptors. Future RNA-seq experiments will be needed
to explore the role of RNA-editing within brain endothelial cells
specifically.
Currently, BBB RNA-seq data is limited to a single dataset from
mouse (at the time this review was submitted), which is already
providing an extensive view of the expression landscape of not
only BECs, but also neurons, astrocytes, oligodendrocytes, and
microglia (Zhang et al., 2014). The authors of this study primar-
ily used FACs and immunopanningmethods to purify specific cell
types, thus minimizing cross contamination and enabling greater
quantitative comparisons. In addition, this valuable dataset has
been made available to the public via a searchable website which
includes differential splicing data (Zhang et al., 2014).
To supplement the paucity of RNA-seq data derived from
the BBB, a recent developmental study using RNA sequenc-
ing to understand brain-CSF barrier formation assembled a
comprehensive list of transcripts differentially enriched between
E15 embryo and P42 adult rat lateral ventricle choroid plexus
(Liddelow et al., 2013). This served as a quantitative approach
to update a prior microarray study (Liddelow et al., 2012).
The authors performed immunohistochemistry to demonstrate
embryonic and choroid plexus epithelium-specific expression
of genes they found enriched via RNA-seq (Liddelow et al.,
2013).
The RNA-seq approach has also been used to profile expres-
sion signatures of single cells. In a study where cultured cortical
neuron transcriptomes of single cells were compared to indi-
vidual layer 5 pyramidal neurons in situ, the authors found that
gene expression levels correlated better amongst single cultured
neurons compared to the single neurons sampled in situ (Qiu
et al., 2012). This in vivo heterogeneity may also apply to cells
of the BBB and thus future gene expression studies sampling
single BECs or capillary fragments from distinct disease regions
or developmental stages of individual vascular branches may
reveal further complexity in expression of specific transporters or
receptors.
5.4. FINAL REMARKS
Advancements in techniques for the isolation and purification
of BECs and in the technologies to study the resulting tran-
scriptomes and proteomes make for an exciting and promising
future for the BBB research community. Transcriptome wide data
for human diseases associated with BBB dysfunction, and cor-
responding animal models are under-represented in the current
selection of BBB data sets. Future studies may also identify sex-
ual dimorphisms to the BBB, how the BBB changes in response to
neuronal activity, during normal aging, as well as following intake
of different drugs. Furthermore, understanding heterogeneity of
the BBB between different segments of the vascular tree as well as
between different regions of the brain may be important in our
understanding of how the BBB interacts with neural cells to regu-
late brain function and behavior. Filling these gaps with data that
are as close to the in vivo setting as possible, and utilizing tech-
niques such as FACS or LCM, will be of great benefit. Finally, the
continued commitment to share newly generated data sets in pub-
licly accessible repositories will undoubtedly propel forward our
understanding of BBB biology at an unprecedented pace.
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 355 | 10
Huntley et al. Gene expression at the blood-brain barrier
ACKNOWLEDGMENTS
We sincerely thank Allison Bruce for her graphics, Sabya Biswas
for LCM imaging, and all the investigators who have shared their
data sets publicly for the benefit of the research community.
REFERENCES
Abbott, N. J. (2005). Dynamics of CNS barriers: evolution, differentiation, and
modulation. Cell Mol. Neurobiol. 25, 5–23. doi: 10.1007/s10571-004-1374-y
Adams, R. H., and Alitalo, K. (2007). Molecular regulation of angiogenesis and
lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464–478. doi: 10.1038/nrm2183
Agarwal, S., Uchida, Y., Mittapalli, R. K., Sane, R., Terasaki, T., and Elmquist, W.
F. (2012). Quantitative proteomics of transporter expression in brain capil-
lary endothelial cells isolated from Pglycoprotein (P-gp), breast cancer resis-
tance protein (Bcrp), and P-gp/Bcrp knockout mice. Drug Metab. Dispos. 40,
1164–1169. doi: 10.1124/dmd.112.044719
Armulik, A., Genove, G., and Betsholtz, C. (2011). Pericytes: developmental, phys-
iological, and pathological perspectives, problems, and promises. Dev. Cell. 21,
193–215. doi: 10.1016/j.devcel.2011.07.001
Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C.,
et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557–561.
doi: 10.1038/nature09522
Badhwar, A., Stanimirovic, D. B., Hamel, E., and Haqqani, A. S. (2014). The pro-
teome of mouse cerebral arteries. J. Cereb. Blood Flow. Metab. 34, 1033–1046.
doi: 10.1038/jcbfm.2014.52
Ball, H. J., McParland, B., Driussi, C., and Hunt, N. H. (2002). Isolating ves-
sels from the mouse brain for gene expression analysis using laser capture
microdissection. Brain Res. Brain Res. Protoc. 9, 206–213. doi: 10.1016/S1385-
299X(02)00147-2
Banerjee, S., Sousa, A. D., and Bhat, M. A. (2006). Organization and function of
septate junctions, an evolutionary perspective. Cell Biochem. Biophys. 46, 65–77.
doi: 10.1385/CBB:46:1:65
Barbier, M., Faille, D., Loriod, B., Textoris, J., Camus, C., Puthier, D., et al. (2011).
Platelets alter gene expression profile in human brain endothelial cells in an
in vitro model of cerebral malaria. PLoS One 6:e19651. doi: 10.1371/jour-
nal.pone.0019651
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., et al. (2014).
Mfsd2a is critical for the formation and function of the blood-brain barrier.
Nature 509, 507–511. doi: 10.1038/nature13324
Betz, A. L., Csejtey, J., and Goldstein, G. W. (1979). Hexose transport and
phosphorylation by capillaries isolated from rat brain. Am. J. Physiol. 236,
c96–c102.
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., and Landfield,
P. W. (2011). Microarray analyses of laser-captured hippocampus reveal dis-
tinct gray and white matter signatures associated with incipient Alzheimer’s
disease. J. Chem. Neuroanat. 42, 118–126. doi: 10.1016/j.jchemneu.2011.
06.007
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and
Landfield, P. W. (2004). Incipient Alzheimer’s disease: microarray correlation
analyses reveal major transcriptional and tumor suppressor responses. Proc.
Natl. Acad. Sci. U.S.A. 101, 2173–2178. doi: 10.1073/pnas.0308512100
Boado, R. J., and Pardridge, M. M. (1991). A one-step procedure for isolation of
poly(A)+ mRNA from isolated brain capillaries and endothelial cells in culture.
J. Neurochem. 57, 2136–2139. doi: 10.1111/j.1471-4159.1991.tb06433.x
Bowman, P. D., Betz, A. L., Ar, D., Wolinsky, J. S., Penney, J. B., Shivers, R. R., et al.
(1981). Primary culture of capillary endothelium from rat brain. In Vitro 17,
353–362. doi: 10.1007/BF02618147
Bowyer, J. F., Patterson, T. A., Saini, U. T., Hanig, J. P., Thomas, M., Camacho, L.,
et al. (2013). Comparison of the global gene expression of choroid plexus and
meninges and associated vasculature under control conditions and after pro-
nounced hyperthermia or amphetamine toxicity. BMC Genom. 14, 147–2164.
doi: 10.1186/1471-2164-14-147
Calabria, A. R., and Shusta, E. V. (2008). A genomic comparison of in vivo and
in vitro brain microvascular endothelial cells. J. Cereb. Blood Flow Metab. 28,
135–148. doi: 10.1038/sj.jcbfm.9600518
Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H.,
et al. (2008). Activated leukocyte cell adhesion molecule promotes leukocyte
trafficking into the central nervous system. Nat. Immunol. 9, 137–145. doi:
10.1038/ni1551
Chun, H. B., Scott, M., Niessen, S., Hoover, H., Baird, A., Yates, J., et al. (2011). The
proteome of mouse brain microvessel membranes and basal lamina. J. Cereb.
Blood Flow Metab. 31, 2267–2281. doi: 10.1038/jcbfm.2011.104
Cunnea, P., McMahon, J., O’Connell, E., Mashayekhi, K., Fitzgerald, U., and
McQuaid, S. (2010). Gene expression analysis of the microvascular com-
partment in multiple sclerosis using laser microdissected blood vessels. Acta
Neuropathol. 119, 601–615. doi: 10.1007/s00401-009-0618-9
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C. J., and Barres, B. A. (2009).
Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogene-
sis. Proc. Natl. Acad. Sci. U.S. A. 106, 641–646. doi: 10.1073/pnas.0805165106
Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A., and Barres, B. A.
(2010a). The mouse blood-brain barrier transcriptome: a new resource for
understanding the development and function of brain endothelial cells. PLoS
ONE 5:e13741. doi: 10.1371/journal.pone.0013741
Daneman, R., Zhou, L., Kebede, A. A., and Barres, B. A. (2010b). Pericytes are
required for blood-brain barrier integrity during embryogenesis. Nature 468,
562–566. doi: 10.1038/nature09513
Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas-Duport, C., Couraud,
P. O., et al. (2008). ABC transporters, cytochromes P450 and their main tran-
scription factors: expression at the human blood-brain barrier. J. Neurochem.
107, 1518–1528. doi: 10.1111/j.1471-4159.2008.05720.x
Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P. S., and
Morgan, D. (2003). Selectively reduced expression of synaptic plasticity-related
genes in amyloid precursor protein + presenilin-1 transgenic mice. J. Neurosci.
23, 5219–5226.
Dieterich, L. C., Mellberg, S., Langenkamp, E., Zhang, L., Zieba, A., Salomaki, H.,
et al. (2012). Transcriptional profiling of human glioblastoma vessels indicates
a key role of VEGF-A and TGFbeta2 in vascular abnormalization. J. Pathol. 228,
378–390. doi: 10.1002/path.4072
Dorr, A., Sled, J. G., and Kabani, N. (2007). Three-dimensional cerebral
vasculature of the CBA mouse brain: a magnetic resonance imaging
and micro computed tomography study. Neuroimage 35, 1409–1423. doi:
10.1016/j.neuroimage.2006.12.040
Dunckley, T., Beach, T. G., Ramsey, K. E., Grover, A., Mastroeni, D.,
Walker, D. G., et al. (2006). Gene expression correlates of neurofibril-
lary tangles in Alzheimer’s disease. Neurobiol. Aging. 27, 1359–1371. doi:
10.1016/j.neurobiolaging.2005.08.013
Eadon, M. T., Jacob, A., Cunningham, P. N., Quigg, R. J., Garcia, J. G., and
Alexander, J. J. (2014). Transcriptional profiling reveals that C5a alters miRNA
in brain endothelial cells. Immunology. 143, 363–373. doi: 10.1111/imm.12314
Enerson, B. E., and Drewes, L. R. (2006). The rat blood-brain barrier transcrip-
tome. J. Cereb. Blood Flow Metab. 26, 959–973. doi: 10.1038/sj.jcbfm.9600249
Engelhardt, B., and Liebner, S. (2014). Novel insights into the development and
maintenance of the blood-brain barrier. Cell Tissue Res. 355, 687–699. doi:
10.1007/s00441-014-1811-2
Falcon, S., and Gentleman, R. (2007). Using GOstats to test gene lists for GO term
association. Bioinformatics 23, 257–258. doi: 10.1093/bioinformatics/btl567
Franzen, B., Duvefelt, K., Jonsson, C., Engelhardt, B., Ottervald, J., Wickman, M.,
et al. (2003). Gene and protein expression profiling of human cerebral endothe-
lial cells activated with tumor necrosis factor-alpha. Brain Res. Mol. Brain Res.
115, 130–146. doi: 10.1016/S0169-328X(03)00185-2
Gatta, V., D’Aurora,M., Granzotto, A., Stuppia, L., and Sensi, S. L. (2014). Early and
sustained altered expression of aging-related genes in young 3xTg-ADmice. Cell
Death Dis. 5:e1054. doi: 10.1038/cddis.2014.11
Geldenhuys, W. J., Allen, D. D., and Bloomquist, J. R. (2012). Novel models
for assessing blood-brain barrier drug permeation. Expert Opin. Drug Metab
Toxicol. 8, 647–653. doi: 10.1517/17425255.2012.677433
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit,
S., et al. (2004). Bioconductor: open software development for computational
biology and bioinformatics.Genome Biol. 5:R80. doi: 10.1186/gb-2004-5-10-r80
Giger, T., Khaitovich, P., Somel, M., Lorenc, A., Lizano, E., Harris, L. W., et al.
(2010). Evolution of neuronal and endothelial transcriptomes in primates.
Genome Biol. Evol. 2, 284–292. doi: 10.1093/gbe/evq018
Goetz, I. E., Warren, J., Estrada, C., Roberts, E., and Krause, D. N. (1985). Long-
term serial cultivation of arterial and capillary endothelium from adult bovine
brain. In Vitro Cell Dev. Biol. 21, 172–180. doi: 10.1007/BF02621355
Harris, L. W., Wayland, M., Lan, M., Ryan, M., Giger, T., Lockstone, H.,
et al. (2008). The cerebral microvasculature in schizophrenia: a laser capture
microdissection study. PLoS ONE 3:e3964. doi: 10.1371/journal.pone.0003964
www.frontiersin.org November 2014 | Volume 8 | Article 355 | 11
Huntley et al. Gene expression at the blood-brain barrier
Haqqani, A. S., Kelly, J., Baumann, E., Haseloff, R. F., Blasig, I. E., and Stanimirovic,
D. B. (2007). Protein markers of ischemic insult in brain endothelial cells iden-
tified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J.
Proteome Res. 6, 226–239. doi: 10.1021/pr0603811
Haqqani, A. S., Nesic, M., Preston, E., Baumann, E., Kelly, J., and Stanimirovic,
D. (2005). Characterization of vascular protein expression patterns in cerebral
ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-
MS/MS. FASEB J. 19, 1809–1821. doi: 10.1096/fj.05-3793com
Hawkins, B. T., and Egleton, R. D. (2008). Pathophysiology of the blood-brain
barrier: animal models and methods. Curr. Top Dev. Biol. 80, 277–309. doi:
10.1016/S0070-2153(07)80007-X
He, Z., Cui, L., Patterson, T. A., and Paule, M. G. (2011). Defining the phosphodi-
esterase superfamily members in rat brain microvessels. ACS Chem. Neurosci. 2,
600–607. doi: 10.1021/cn2000487
Himburg, H. A., Muramoto, G. G., Daher, P., Meadows, S. K., Russell, J. L.,
Doan, P., et al. (2010). Pleiotrophin regulates the expansion and regeneration
of hematopoietic stem cells. Nat. Med. 16, 475–482. doi: 10.1038/nm.2119
Hudson, L. C., Bragg, D. C., Tompkins, M. B., and Meeker, R. B. (2005).
Astrocytes and microglia differentially regulate trafficking of lymphocyte
subsets across brain endothelial cells. Brain Res. 1058, 148–160. doi:
10.1016/j.brainres.2005.07.071
Ifergan, I., Kebir, H., Terouz, S., Alvarez, J. I., Lecuyer, M. A., Gendron, S., et al.
(2011). Role of Ninjurin-1 in the migration of myeloid cells to central ner-
vous system inflammatory lesions. Ann. Neurol. 70, 751–763. doi: 10.1002/ana.
22519
Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J.,
Scherf, U., et al. (2003). Exploration, normalization, and summaries of high
density oligonucleotide array probe level data. Biostatistics 4, 249–264. doi:
10.1093/biostatistics/4.2.249
Ito, K., Uchida, Y., Ohtsuki, S., Aizawa, S., Kawakami, H., Katsukura, Y., et al.
(2011). Quantitative membrane protein expression at the blood-brain barrier
of adult and younger cynomolgus monkeys. J. Pharm. Sci. 100, 3939–3950. doi:
10.1002/jps.22487
Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., Yanai, K., et al.
(2008). Quantitative atlas of membrane transporter proteins: development and
application of a highly sensitive simultaneous LC/MS/MS method combined
with novel in-silico peptide selection criteria. Pharm. Res. 25, 1469–1483. doi:
10.1007/s11095-008-9532-4
Kauffmann, A., Gentleman, R., and Huber, W. (2009). arrayQualityMetrics–a bio-
conductor package for quality assessment of microarray data. Bioinformatics 25,
415–416. doi: 10.1093/bioinformatics/btn647
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., and Blasig,
I. E. (2008). Structure and function of claudins. Biochim. Biophys. Acta. 1778,
631–645. doi: 10.1016/j.bbamem.2007.10.018
Lazarov, O., Robinson, J., Tang, Y. P., Hairston, I. S., Korade-Mirnics, Z., Lee,
V. M., et al. (2005). Environmental enrichment reduces Abeta levels and amy-
loid deposition in transgenic mice. Cell 120, 701–713. doi: 10.1016/j.cell.2005.
01.015
Li, J. Y., Boado, R. J., and Pardridge, W. M. (2001). Blood-brain barrier genomics. J.
Cereb. Blood Flow Metab. 21, 61–68. doi: 10.1097/00004647-200101000-00008
Li, K., Dong, D., Yao, L., Dai, D., Gu, X., and Guo, L. (2008). Identification of STC1
as an beta-amyloid activated gene in human brain microvascular endothelial
cells using cDNA microarray. Biochem. Biophys. Res. Commun. 376, 399–403.
doi: 10.1016/j.bbrc.2008.08.158
Liddelow, S. A., Dziegielewska, K. M., Ek, C. J., Habgood, M. D., Bauer, H., Bauer,
H. C., et al. (2013). Mechanisms that determine the internal environment of
the developing brain: a transcriptomic, functional and ultrastructural approach.
PLoS ONE 8:e65629. doi: 10.1371/journal.pone.0065629
Liddelow, S. A., Temple, S., Mollgard, K., Gehwolf, R., Wagner, A., Bauer, H., et al.
(2012). Molecular characterisation of transport mechanisms at the developing
mouse blood-CSF interface: a transcriptome approach. PLoS ONE 7:e33554.
doi: 10.1371/journal.pone.0033554
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., et al.
(2008). Wnt/beta-catenin signaling controls development of the blood-brain
barrier. J. Cell Biol. 183, 409–417. doi: 10.1083/jcb.200806024
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E. H., Kalbacher, H.,
et al. (2000). Claudin-1 and claudin-5 expression and tight junction mor-
phology are altered in blood vessels of human glioblastoma multiforme. Acta
Neuropathol. 100, 323–331. doi: 10.1007/s004010000180
Lindahl, P., Johansson, B. R., Leveen, P., and Betsholtz, C. (1997). Pericyte loss and
microaneurysm formation in PDGF-B-deficient mice. Science 277, 242–245.
doi: 10.1126/science.277.5323.242
Lister, R., O’Malley, R. C., Tonti-Filippini, J., Gregory, B. D., Berry, C. C., Millar,
A. H., et al. (2008). Highly integrated single-base resolution maps of the
epigenome in Arabidopsis. Cell 133, 523–536. doi: 10.1016/j.cell.2008.03.029
Lopez-Ramirez, M. A., Male, D. K., Wang, C., Sharrack, B., Wu, D., and Romero,
I. A. (2013). Cytokine-induced changes in the gene expression profile of a
human cerebral microvascular endothelial cell-line, hCMEC/D3. Fluids Barriers
CNS 10, 27–8118. doi: 10.1186/2045-8118-10-27
Lyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., et al.
(2009). Culture-induced changes in blood-brain barrier transcriptome: impli-
cations for amino-acid transporters in vivo. J. Cereb. Blood Flow Metab. 29,
1491–1502. doi: 10.1038/jcbfm.2009.72
Lu, L., Yang, P.-Y., Rui, Y.-Ch., Kang, H., Zhang, J., Zhang, J.-P., et al. (2007).
Comparative proteome analysis of rat brain and coronary microvascular
endothelial cells. Physiol. Res. 56, 159–168.
Lu, Q., Murugesan, N., Macdonald, J. A., Wu, S. L., Pachter, J. S., and Hancock,
W. S. (2008). Analysis of mouse brain microvascular endothelium using
immuno-laser capture microdissection coupled to a hybrid linear ion trap with
Fourier transform-mass spectrometry proteomics platform. Electrophoresis 29,
2689–2695. doi: 10.1002/elps.200700936
Macdonald, J. A., Murugesan, N., and Pachter, J. S. (2008). Validation of immuno-
laser capture microdissection coupled with quantitative RT-PCR to probe
blood-brain barrier gene expression in situ. J. Neurosci. Methods. 174, 219–226.
doi: 10.1016/j.jneumeth.2008.07.009
Macdonald, J. A., Murugesan, N., and Pachter, J. S. (2010). Endothelial cell hetero-
geneity of blood-brain barrier gene expression along the cerebral microvascula-
ture. J. Neurosci. Res. 88, 1457–1474. doi: 10.1002/jnr.22316
Marques, F., Sousa, J. C., Sousa, N., and Palha, J. A. (2013). Blood-brain-barriers
in aging and in Alzheimer’s disease. Mol. Neurodegener. 8, 38–1326. doi:
10.1186/1750-1326-8-38
Marroni, M., Kight, K. M., Hossain, M., Cucullo, L., Desai, S. Y., and Janigro,
D. (2003). Dynamic in vitro model of the blood-brain barrier. Gene profil-
ing using cDNA microarray analysis. Methods Mol. Med. 89, 419–434. doi:
10.1385/1-59259-419-0:419
Masuda, S., Oda, Y., Sasaki, H., Ikenouchi, J., Higashi, T., Akashi, M., et al. (2011).
LSR defines cell corners for tricellular tight junction formation in epithelial cells.
J. Cell Sci. 124, 548–555. doi: 10.1242/jcs.072058
Mayer, F., Mayer, N., Chinn, L., Pinsonneault, R. L., Kroetz, D., and Bainton,
R. J. (2009). Evolutionary conservation of vertebrate blood-brain barrier
chemoprotective mechanisms in Drosophila. J. Neurosci. 29, 3538–3550. doi:
10.1523/JNEUROSCI.5564-08.2009
McCandless, E. E., Budde, M., Lees, J. R., Dorsey, D., Lyng, E., and Klein, R. S.
(2009). IL-1R signaling within the central nervous system regulates CXCL12
expression at the blood-brain barrier and disease severity during experimental
autoimmune encephalomyelitis. J. Immunol. 183, 613–620. doi: 10.4049/jim-
munol.0802258
McCandless, E. E., Wang, Q., Woerner, B. M., Harper, J. M., and Klein, R. S.
(2006). CXCL12 limits inflammation by localizing mononuclear infiltrates to
the perivascular space during experimental autoimmune encephalomyelitis. J.
Immunol. 177, 8053–8064. doi: 10.4049/jimmunol.177.11.8053
Mojsilovic-Petrovic, J., Nesic, M., Pen, A., Zhang, W., and Stanimirovic, D. (2004).
Development of rapid staining protocols for laser-capture microdissection of
brain vessels from human and rat coupled to gene expression analyses. J.
Neurosci. Methods. 133, 39–48. doi: 10.1016/j.jneumeth.2003.09.026
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., and Wold, B. (2008).
Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat.
Methods 5, 621–628. doi: 10.1038/nmeth.1226
Murugesan, N.,Macdonald, J. A., Lu, Q.,Wu, S. L., Hancock,W. S., and Pachter, J. S.
(2011). Analysis of mouse brain microvascular endothelium using laser capture
microdissection coupled with proteomics.Methods Mol. Biol. 686, 297–311. doi:
10.1007/978-1-60761-938-3-14
Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M., et al.
(2008). The transcriptional landscape of the yeast genome defined by RNA
sequencing. Science 320, 1344–1349. doi: 10.1126/science.1158441
Navone, S. E., Marfia, G., Invernici, G., Cristini, S., Nava, S., Balbi, S., et al. (2013).
Isolation and expansion of human and mouse brain microvascular endothelial
cells. Nat. Protoc. 8, 1680–1693. doi: 10.1038/nprot.2013.107
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 355 | 12
Huntley et al. Gene expression at the blood-brain barrier
Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X.,
et al. (2014). Mfsd2a is a transporter for the essential omega-3 fatty acid
docosahexaenoic acid. Nature 509, 503–506. doi: 10.1038/nature13241
Nielsen, P. A., Andersson, O., Hansen, S. H., Simonsen, K. B., and Andersson,
G. (2011). Models for predicting blood-brain barrier permeation. Drug Discov.
Today. 16, 472–475. doi: 10.1016/j.drudis.2011.04.004
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., et al. (2003). Size-
selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell
Biol. 161, 653–660.
Obermeier, B., Daneman, R., and Ransohoff, R. M. (2013). Development, mainte-
nance and disruption of the blood-brain barrier. Nat. Med. 19, 1584–1596. doi:
10.1038/nm.3407
Ohtsuki, S., Ikeda, C., Uchida, Y., Sakamoto, Y., Miller, F., Glacial, F., et al. (2013).
Quantitative targeted absolute proteomic analysis of transporters, receptors and
junction proteins for validation of human cerebral microvascular endothelial
cell line hCMEC/D3 as a human blood-brain barrier model. Mol. Pharm. 10,
289–296. doi: 10.1021/mp3004308
Ouyang, S., Hsuchou, H., Kastin, A. J., Wang, Y., Yu, C., and Pan, W. (2014).
Diet-induced obesity suppresses expression of many proteins at the blood-brain
barrier. J. Cereb. Blood Flow Metab. 34, 43–51. doi: 10.1038/jcbfm.2013.166
Pen, A., Moreno, M. J., Martin, J., and Stanimirovic, D. B. (2007). Molecular
markers of extracellular matrix remodeling in glioblastoma vessels: microarray
study of laser-captured glioblastoma vessels.Glia 55, 559–572. doi: 10.1002/glia.
20481
Pfeiffer, F., Schafer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N.,
et al. (2011). Claudin-1 induced sealing of blood-brain barrier tight junc-
tions ameliorates chronic experimental autoimmune encephalomyelitis. Acta
Neuropathol. 122, 601–614. doi: 10.1007/s00401-011-0883-2
Pottiez, G., Deracinois, B., Duban-Deweer, S., Cecchelli, R., Fenart, L., Karamanos,
Y., et al. (2010). A large-scale electrophoresis- and chromatography-based deter-
mination of gene expression profiles in bovine brain capillary endothelial cells
after the re-induction of blood-brain barrier properties. Proteome Sci. 8:57. doi:
10.1186/1477-5956-8-57
Pottiez, G., Flahaut, C., Cecchelli, R., and Karamanos, Y. (2009). Understanding the
blood-brain barrier using gene and protein expression profiling technologies.
Brain Res. Rev. 62, 83–98. doi: 10.1016/j.brainresrev.2009.09.004
Qiu, S., Luo, S., Evgrafov, O., Li, R., Schroth, G. P., Levitt, P., et al. (2012). Single-
neuron RNA-Seq: technical feasibility and reproducibility. Front. Genet. 3:124.
doi: 10.3389/fgene.2012.00124
Reddy, P. H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D.,
et al. (2004). Gene expression profiles of transcripts in amyloid precursor pro-
tein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic
genes is an early cellular change in Alzheimer’s disease. Hum. Mol. Genet. 13,
1225–1240. doi: 10.1093/hmg/ddh140
Reese, T. S., and Karnovsky, M. J. (1967). Fine structural localization of a
blood-brain barrier to exogenous peroxidase. J. Cell. Biol. 34, 207–217. doi:
10.1083/jcb.34.1.207
Reijerkerk, A., Lopez-Ramirez, M. A., van Het Hof, B., Drexhage, J. A., Kamphuis,
W. W., Kooij, G., et al. (2013). MicroRNAs regulate human brain endothe-
lial cell-barrier function in inflammation: implications for multiple sclerosis.
J. Neurosci. 33, 6857–6863. doi: 10.1523/JNEUROSCI.3965-12.2013
Risau, W., Hallmann, R., and Albrecht, U. (1986). Differentiation-dependent
expression of proteins in brain endothelium during development of the
blood-brain barrier. Dev. Biol. 117, 537–545. doi: 10.1016/0012-1606(86)
90321-0
Saunders, N. R., Daneman, R., Dziegielewska, K. M., and Liddelow, S. A. (2013).
Transporters of the blood-brain and blood-CSF interfaces in development and
in the adult. Mol. Aspects Med. 34, 742–752. doi: 10.1016/j.mam.2012.11.006
Schwabe, T., Bainton, R. J., Fetter, R. D., Heberlein, U., and Gaul, U. (2005). GPCR
signaling is required for blood-brain barrier formation in drosophila. Cell 123,
133–144. doi: 10.1016/j.cell.2005.08.037
Searcy, J. L., Le Bihan, T., Salvadores, N., McCulloch, J., and Horsburgh, K. (2014).
Impact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI
mice. PLoS ONE 9:e89970. doi: 10.1371/journal.pone.0089970
Shawahna, R., Uchida, Y., Decleves, X., Ohtsuki, S., Yousif, S., Dauchy,
S., et al. (2011). Transcriptomic and quantitative proteomic analy-
sis of transporters and drug metabolizing enzymes in freshly isolated
human brain microvessels. Mol. Pharm. 8, 1332–1341. doi: 10.1021/mp
200129p
Shusta, E. V. (2005). Blood-brain barrier genomics, proteomics, and new trans-
porter discovery. NeuroRx 2, 151–161. doi: 10.1602/neurorx.2.1.151
Shusta, E. V., Boado, R. J., Mathern, G. W., and Pardridge, W. M. (2002). Vascular
genomics of the human brain. J. Cereb. Blood Flow Metab. 22, 245–252. doi:
10.1097/00004647-200203000-00001
Siegenthaler, J. A., Sohet, F., and Daneman, R. (2013). ’Sealing off the CNS’: cellular
and molecular regulation of blood-brain barriergenesis. Curr. Opin. Neurobiol.
23, 1057–1064. doi: 10.1016/j.conb.2013.06.006
Smyth, G. K. (2004). Linear models and empirical bayes methods for assess-
ing differential expression in microarray experiments. Stat. Appl. Genet. Mol.
Biol. 3:3. doi: 10.2202/1544-6115.1027
Stenman, J. M., Rajagopal, J., Carroll, T. J., Ishibashi, M., McMahon, J., and
McMahon, A. P. (2008). Canonical Wnt signaling regulates organ-specific
assembly and differentiation of CNS vasculature. Science 322, 1247–1250. doi:
10.1126/science.1164594
Stork, T., Engelen, D., Krudewig, A., Silies, M., Bainton, R. J., and Klambt, C.
(2008). Organization and function of the blood-brain barrier in Drosophila.
J. Neurosci. 28, 587–597. doi: 10.1523/JNEUROSCI.4367-07.2008
Tam, S. J., Richmond, D. L., Kaminker, J. S., Modrusan, Z., Martin-McNulty, B.,
Cao, T. C., et al. (2012). Death receptors DR6 and TROY regulate brain vascular
development. Dev. Cell 22, 403–417. doi: 10.1016/j.devcel.2011.11.018
Tam, S. J., and Watts, R. J. (2010). Connecting vascular and nervous system devel-
opment: angiogenesis and the blood-brain barrier. Annu. Rev. Neurosci. 33,
379–408. doi: 10.1146/annurev-neuro-060909-152829
Triguero, D., Buciak, J., and Pardridge, W. M. (1990). Capillary depletion method
for quantification of blood-brain barrier transport of circulating peptides
and plasma proteins. J. Neurochem. 54, 1882–1888. doi: 10.1111/j.1471-
4159.1990.tb04886.x
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., et al. (2011).
Quantitative targeted absolute proteomics of human blood-brain barrier
transporters and receptors. J. Neurochem. 117, 333–345. doi: 10.1111/j.1471-
4159.2011.07208.x
Urich, E., Lazic, S. E., Molnos, J., Wells, I., and Freskgard, P. O. (2012).
Transcriptional profiling of human brain endothelial cells reveals key properties
crucial for predictive in vitro blood-brain barrier models. PLoS ONE 7:e38149.
doi: 10.1371/journal.pone.0038149
Vinters, H. V., Reave, S., Costello, P., Girvin, J. P., andMoore, S. A. (1987). Isolation
and culture of cells derived from human cerebral microvessels. Cell Tissue Res.
249, 657–667. doi: 10.1007/BF00217338
Wang, S., Qaisar, U., Yin, X., and Grammas, P. (2012a). Gene expression profiling
in Alzheimer’s disease brain microvessels. J. Alzheimers Dis. 31, 193–205. doi:
10.3233/JAD-2012-120454
Wang, Y., Rattner, A., Zhou, Y., Williams, J., Smallwood, P. M., and Nathans, J.
(2012b). Norrin/Frizzled4 signaling in retinal vascular development and blood
brain barrier plasticity. Cell 151, 1332–1344. doi: 10.1016/j.cell.2012.10.042
Webster, J. A., Gibbs, J. R., Clarke, J., Ray, M., Zhang, W., Holmans, P., et al. (2009).
Genetic control of human brain transcript expression in Alzheimer disease. Am.
J. Hum. Genet. 84, 445–458. doi: 10.1016/j.ajhg.2009.03.011
Wilhelm, B. T., Marguerat, S., Watt, S., Schubert, F., Wood, V., Goodhead, I., et al.
(2008). Dynamic repertoire of a eukaryotic transcriptome surveyed at single-
nucleotide resolution. Nature 453, 1239–1243. doi: 10.1038/nature07002
Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner,
S., Hamm, S., et al. (2003). Localization of claudin-3 in tight junctions of
the blood-brain barrier is selectively lost during experimental autoimmune
encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105,
586–592. doi: 10.1007/s00401-003-0688-z
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian,
R., et al. (2007). Angiotensin II controls occludin function and is required for
blood brain barrier maintenance: relevance to multiple sclerosis. J. Neurosci. 27,
9032–9042. doi: 10.1523/JNEUROSCI.2088-07.2007
Wu, V. M., and Beitel, G. J. (2004). A junctional problem of apical proportions:
epithelial tube-size control by septate junctions in the Drosophila tracheal
system. Curr. Opin. Cell Biol. 16, 493–499. doi: 10.1016/j.ceb.2004.07.008
Yousif, S., Marie-Claire, C., Roux, F., Scherrmann, J. M., and Decleves, X. (2007).
Expression of drug transporters at the blood-brain barrier using an opti-
mized isolated rat brain microvessel strategy. Brain Res. 1134, 1–11. doi:
10.1016/j.brainres.2006.11.089
Yu, Y. J., andWatts, R. J. (2013). Developing therapeutic antibodies for neurodegen-
erative disease. Neurotherapeutics 10, 459–472. doi: 10.1007/s13311-013-0187-4
www.frontiersin.org November 2014 | Volume 8 | Article 355 | 13
Huntley et al. Gene expression at the blood-brain barrier
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O’Keeffe, S.,
et al. (2014). An RNA-Sequencing Transcriptome and Splicing Database of
Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci. 34,
11929–11947. doi: 10.1523/JNEUROSCI.1860-14.2014
Zhou, L., Sohet, F., and Daneman, R. (2014a). Purification and culture of central
nervous system endothelial cells. Cold Spring Harb. Protoc. 2014, 44–46. doi:
10.1101/pdb.top070987
Zhou, Y., Wang, Y., Tischfield, M., Williams, J., Smallwood, P. M., Rattner, A., et al.
(2014b). Canonical WNT signaling components in vascular development and
barrier formation. J. Clin. Invest. 124, 3825–3846. doi: 10.1172/JCI76431
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 19 August 2014; paper pending published: 07 September 2014; accepted: 15
October 2014; published online: 06 November 2014.
Citation: Huntley MA, Bien-Ly N, Daneman R and Watts RJ (2014) Dissecting
gene expression at the blood-brain barrier. Front. Neurosci. 8:355. doi: 10.3389/fnins.
2014.00355
This article was submitted to Neurogenomics, a section of the journal Frontiers in
Neuroscience.
Copyright © 2014 Huntley, Bien-Ly, Daneman and Watts. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, pro-
vided the original author(s) or licensor are credited and that the original publi-
cation in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 355 | 14
